Mu- and kappa-opiate receptor control of prolactin secretion in rats: ontogeny and interaction with serotonin
- PMID: 1332851
- DOI: 10.1210/endo.131.6.1332851
Mu- and kappa-opiate receptor control of prolactin secretion in rats: ontogeny and interaction with serotonin
Abstract
The present study explores developmental changes in mu- and kappa-opiate receptor control of PRL secretion. The ontogeny of mu- and kappa-receptor function was determined by assessing the PRL response to the mu-agonist sufentanil (SUF) and the kappa-agonist U50488 in 5-, 10-, 15-, 20-, and 60-day-old rats. Both mu- and kappa-agonists stimulated PRL secretion at all ages. The selectivity of the mu- and kappa-agonists was confirmed by selective blockade with their respective antagonists (beta-funaltrexamine and nor-binaltorphimine). Serotonin mediation of opiate-induced changes in PRL secretion was explored across ontogeny by testing cyproheptadine (CYPRO) blockade of agonist responses in 5-, 10-, 20-, and 60-day-old rats. CYPRO attenuated the PRL response to the mu-agonist SUF in 20- and 60-day-old rats, but not in the 5- or 10-day-old pups. CYPRO did not block the kappa-agonist U50488 at any age. Similarly, pretreatment with parachlorophenylalaine lowered the PRL response to SUF in 60-day-old rats, but not in 10-day-old rats. These results support previous reports of a serotonin-mediated mu control of PRL secretion that develops by day 20 and a kappa control of PRL secretion that is independent of serotonin at all ages. These findings also suggest that a previously reported serotonin-independent mu-receptor-mediated control of PRL secretion can be stimulated early in ontogeny.
Similar articles
-
Early ontogeny of kappa-opioid receptor regulation of prolactin secretion in the rat.Brain Res. 1987 Dec 15;465(1-2):189-96. doi: 10.1016/0165-3806(87)90240-9. Brain Res. 1987. PMID: 2894234
-
Ontogeny of mu- and kappa-opiate receptor control of the hypothalamo-pituitary-adrenal axis in rats.Endocrinology. 1991 Aug;129(2):959-64. doi: 10.1210/endo-129-2-959. Endocrinology. 1991. PMID: 1649751
-
Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.Neuroendocrinology. 1986;42(1):75-81. doi: 10.1159/000124252. Neuroendocrinology. 1986. PMID: 3001565
-
Inhibition of tuberoinfundibular dopaminergic neural activity during suckling: involvement of mu and kappa opiate receptor subtypes.J Neuroendocrinol. 1996 Oct;8(10):771-6. doi: 10.1046/j.1365-2826.1996.05207.x. J Neuroendocrinol. 1996. PMID: 8910807
-
Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.Br J Pharmacol. 1997 Mar;120(6):1001-6. doi: 10.1038/sj.bjp.0700995. Br J Pharmacol. 1997. PMID: 9134209 Free PMC article.
Cited by
-
Limited effects of beta-endorphin compared to loperamide or fentanyl in a neuroendocrine biomarker assay in non-human primates.Psychoneuroendocrinology. 2008 Apr;33(3):292-304. doi: 10.1016/j.psyneuen.2007.11.011. Epub 2008 Jan 2. Psychoneuroendocrinology. 2008. PMID: 18171605 Free PMC article.
-
Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans.Biol Psychiatry. 2012 Nov 15;72(10):871-9. doi: 10.1016/j.biopsych.2012.06.012. Epub 2012 Jul 18. Biol Psychiatry. 2012. PMID: 22817868 Free PMC article. Clinical Trial.
-
A history of chronic morphine exposure during adolescence increases despair-like behaviour and strain-dependently promotes sociability in abstinent adult mice.Behav Brain Res. 2013 Apr 15;243:44-52. doi: 10.1016/j.bbr.2012.12.049. Epub 2013 Jan 4. Behav Brain Res. 2013. PMID: 23295400 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials